Please use this identifier to cite or link to this item:
http://hdl.handle.net/123456789/2342Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.date.accessioned | 2019-11-28T05:19:02Z | - |
| dc.date.available | 2019-11-28T05:19:02Z | - |
| dc.date.issued | 2005-03 | - |
| dc.identifier.uri | http://hdl.handle.net/123456789/2342 | - |
| dc.language.iso | en | en_US |
| dc.publisher | CENTRAL DRUGS STANDARD CONTROL ORGANIZATION, DIRECTORATE GENERAL OF HEALTH SERVICES,MINISTRY OF HEALTH & FAMILY WELFARE,GOVT. OF INDIA, NEW DELHI | en_US |
| dc.title | GUIDELINES FOR BIOAVAILABILITY & BIOEQUIVALENCE STUDIES | en_US |
| dc.type | Learning Object | en_US |
| Appears in Collections: | Reference Material | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| bioavailability study design.pdf | 98.66 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.